| Single SERCA2a therapy ameliorated dilated cardiomyopathy for 18 months in a mouse model of Duchenne muscular dystrophy NB Wasala, Y Yue, W Lostal, LP Wasala, N Niranjan, RJ Hajjar, GJ Babu, ... Molecular therapy 28 (3), 845-854, 2020 | 37 | 2020 |
| Sarcolipin overexpression impairs myogenic differentiation in Duchenne muscular dystrophy N Niranjan, S Mareedu, Y Tian, K Kodippili, N Fefelova, A Voit, LH Xie, ... American Journal of Physiology-Cell Physiology 317 (4), C813-C824, 2019 | 27 | 2019 |
| Sarcolipin haploinsufficiency prevents dystrophic cardiomyopathy in mdx mice S Mareedu, R Pachon, J Thilagavathi, N Fefelova, R Balakrishnan, ... American Journal of Physiology-Heart and Circulatory Physiology 320 (1 …, 2021 | 19 | 2021 |
| Klf9 plays a critical role in GR –dependent metabolic adaptations in cardiomyocytes DS Chandni Thakkar a 1, Saleena Alikunju a 1, Nandita Niranjan a, Wajiha ... Cellular Signalling, 2023 | 2 | 2023 |
| G3bp1–microRNA-1 axis regulates cardiomyocyte hypertrophy S Alikunju, N Niranjan, M Mohsin, N Sayed, D Sayed Cellular signalling 91, 110245, 2022 | 2 | 2022 |
| Sarcolipin knockdown therapy for duchenne muscular dystrophy S Mareedu, S Dwivedi, N Niranjan, GJ Babu Muscle Gene Therapy, 405-415, 2019 | 2 | 2019 |
| AAV-SERCA2a Gene Therapy Ameliorated Muscle Disease in Duchenne Muscular Dystrophy Dogs K Kodippili, CH Hakim, HT Yang, Y Yue, N Niranjan, RJ Hajjar, NN Yang, ... MOLECULAR THERAPY 26 (5), 6-6, 2018 | 1 | 2018 |
| Altered GR-Klf signaling contributes to cardiomyocyte inflammaging S Alikunju, N Niranjan, Z Yang, D Sayed Journal of Molecular and Cellular Cardiology 173, S158, 2022 | | 2022 |
| Long-Term AAV-9 SERCA2a Gene Therapy Ameliorated Dilated Cardiomyopathy in an Aged Mouse Model of Duchenne Muscular Dystrophy NB Wasala, Y Yue, W Lostal, LP Wasala, N Niranjan, RJ Hajjar, G Babu, ... MOLECULAR THERAPY 26 (5), 69-69, 2018 | | 2018 |
